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Abstract
Background: Osseointegration depends on the implant surface, bone quality and the local and systemic host
environment, which can differ in male and female patients. This study was undertaken in order to determine if
male and female cells respond differently to titanium surfaces that have micron-scale roughness and if interactions
of calciotropic hormones [1a,25(OH)2D3 and 17b-oestradiol (E2)] and microstructured surfaces on osteoblasts are
sex dependent.
Methods: Osteoblasts from 6-week old Sprague-Dawley rats were cultured on tissue culture polystyrene (TCPS) or
on titanium (Ti) disks with two different surface topographies, a smooth pretreated (PT) surface and a coarse grit-
blasted/acid-etched (SLA) surface, and treated with 1a,25(OH)2D3,E 2,o rE 2 conjugated to bovine serum albumin
(E2-BSA).
Results: Male and female cells responded similarly to Ti microstructure with respect to cell number and levels of
osteocalcin, transforming growth factor-b1, osteoprotegerin and prostaglandin E2 in their conditioned media,
exhibiting a more differentiated phenotype on SLA than on PT or TCPS. E2 and E2-BSA increased differentiation and
local factor production, an effect that was microstructure dependent and found only in female osteoblasts. 1a,25
(OH)2D3 increased osteoblast differentiation and local factor production in female and male cells, but the effect
was more robust in male cells.
Conclusions: Male and female rat osteoblasts respond similarly to surface microstructure but exhibit sexual
dimorphism in substrate-dependent responses to systemic hormones. Oestrogen affected only female cells while
1a,25(OH)2D3 had a greater effect on male cells. These results suggest that successful osseointegration in males
and females may depend on the implant surface design and correct levels of calciotropic hormones.
Background
Orthopaedic diseases, such as osteoporosis, osteoarthri-
tis and some spinal disorders, are more prevalent in
women [1]. Until recently, most of these differences
were attributed to the circulating levels of oestrogen and
testosterone. However, there is increasing evidence that
sexual dimorphism occurs before puberty and depends
on fundamental differences at the genetic level. Bone
properties, including size and shape, are inherited differ-
ently in males and females [2]. Components of the
extracellular matrix (small integrin binding, N-linked
glycoproteins [SIBLING]) are encoded on the X-chro-
mosome, causing differential expression of resulting syn-
dromes [3]. Sexual dimorphism also exists in lineage
preference of mesenchymal stem cells (MSCs) [4,5].
An ageing population has increased demand for dental
implants to replace missing teeth and orthopaedic
implants to restore function. Successful osseointegration
of these implants, defined as direct contact between
bone and the implant surface under loading conditions
[6,7], depends in part on bone quality and the local and
systemic host environment. Studies have shown lower
osseointegration rates in osteopenic bone than in nor-
mal bone [8]; in osteoporotic animals osseointegration is
50% slower than in normal experimental animals [9,10].
Moreover, clinical trials have shown that osteoporosis is
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and females [11] and that age is a major contributing
factor [12].
Age certainly is an important variable, but systemic
hormones also contribute to early implant failure. In
oestrogen-deficient animals, osseointegration is
impaired, and this represented by less bone mass, a
smaller contact area between bone and the implant
[13,14] and decreased pull-out strength of implants [15].
Similarly, postmenopausal women have had significantly
more failures of maxillary implants than their premeno-
pausal counterparts [16]. One possibility is that there is
a biphasic effect of female gonadal hormone deficiency,
which may temporarily interfere in early implant-tissue
integration and may be associated with a failure to upre-
gulate a select set of bone extracellular matrix genes [9].
Some studies suggest that oestrogen replacement ther-
apy may promote bone healing around titanium (Ti)
implants in osteoporotic bone [17,18]. However, other
studies do not show improved implant success rates
[12]. This raises the possibility that the design of the
implant may also be a contributing factor. Female osteo-
blasts are sensitive to differences in surface morphology
and their responses to oestrogen vary with the surface
properties [19]. Oestrogen is also necessary for bone
strength in males [20] and male osteoblasts are sensitive
to differences in the surface properties of Ti and Ti
alloy implants [21-23], but whether oestrogen regulates
the response of male osteoblasts to orthopaedic implant
materials is not known.
The vitamin D metabolite 1,25-dihydroxyvitamin D3
[1a,25(OH)2D3] is another important factor regulating
osteoblast differentiation and bone formation. The pre-
valence of vitamin D deficiency is relatively higher in
certain populations, such as the elderly [24], pregnant
women in the northern USA [25] or people with limited
sun exposure [26]. Recent reports indicate that fracture
healing is reduced in vitamin D deficient women [27],
suggesting that 1a,25(OH)2D3 may also modulate osteo-
blasts in a sex specific manner.
Successful osseointegration of an implant depends on
its surface properties. In vivo, osteoblasts proliferate
and differentiate in areas of bone conditioned by
osteoclasts, leaving a micron-scale roughness [28].
Microstructured Ti and Ti-6Al-4V surfaces, with a
roughness similar to that found in the resorption lacu-
nae left by osteoclasts [29], result in higher bone-to-
implant contact and stronger mechanical integration in
vivo than smooth surfaces, resulting in better osseoin-
tegration [30-33]. This result is supported by in vitro
findings showing that microstructured surfaces
enhance osteoblast differentiation, matrix deposition
and the production of osteogenic growth factors
[21-23], which regulate the cells via autocrine and
paracrine pathways [34-36]. Osteoblast response to
exogenous regulators, including systemic osteotropic
hormones, is also sensitive to surface properties. The
effects of 1a,25(OH)2D3 on human osteoblast-like
MG63 cells, normal human osteoblasts, fetal rat calvar-
ial cells and mouse osteocyte-like cells are enhanced
on rougher surfaces [37,38].
T h ea i mo ft h ep r e s e n ts t u d yw a st od e t e r m i n ei f
sexual dimorphism in osteoblasts involves a differential
response to implant surface microstructure and if the
interactions between the response to surface micro-
structure and the calciotropic hormones 1a,25(OH)2D3
and 17b-oestradiol are sex-dependent. The study was
performed using primary osteoblasts isolated from
adult male and female rats. However, it does not
address the question of whether sexual dimorphism at
the cell level affects the long-term success of orthopae-
dic implants in vivo.
Methods
We used an in vitro model to determine whether male
and female osteoblasts exhibit differential responses to
Ti surface microstructure and if there are substrate
dependent differences in response to systemic hor-
mones. Primary rat osteoblasts were cultured to conflu-
ence on Ti disks with three different surface
morphologies. At confluence, they were treated for 24
hours with oestrogen (17b-oestradiol) or with 1a,2 5
(OH)2D3. Outcome measures included cell number,
alkaline phosphatase specific activity, osteocalcin pro-
duction and the production of growth factors. In each
experiment there were six independent cultures per
variable (male, female, surface, hormone concentration)
and all experiments were repeated to ensure the validity
of the findings.
Disk preparation
Ti disks with a 15 mm diameter were prepared from Ti
sheets as described previously [29]. Pretreatment disks
(PT) were cleaned by washing in acetone and processing
them through a 2% ammonium fluoride/2% hydrofluoric
acid/10% nitric acid solution at 55°C for 30 s. In order
to produce disks with a mixed micron scale and submi-
cron scale topography (coarse grit-blasted/acid-etched,
SLA), PT disks were coarse grit-blasted with 0.25-0.50
mm corundum until the surface reached a uniform gray
tone, followed by acid etching. The surface parameters
for each of the surfaces have been described in detail
[39]. The PT surface is comparatively smooth with an
average peak to valley roughness (Ra) of 40 nm. The
SLA surface is characterized by 30 to 100 μmc r a t e r s
overlaid with 1-3 μm pits, resulting in an Ra of 3.2 μm.
Control cultures were grown on standard tissue culture
polystyrene (TCPS).
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Osteoblasts were isolated from frontal and parietal (cal-
varia) bones of 6-week-old male (n = 8) and female (n =
8) Sprague-Dawley rats using an explant isolation tech-
nique [40]. Periosteum and soft tissues were removed
from the bones. Pieces with a 1-2 mm diameter were
washed three times in Hank’s balanced salt solution
(HBSS) containing penicillin-streptomycin, and digested
for 15 minutes at 37°C with 0.25% trypsin-ethylenedia-
minetetraacetic acid (EDTA; Invitrogen, CA, USA). The
digestion was discarded in order to avoid fibroblast con-
tamination. The bone chips were placed in a 100 × 20
Petri dish (BD, NJ, USA) and cultured in Dulbecco’s
modified Eagle medium (DMEM; cellgro®, Mediatech,
Inc, VA, USA) containing 1% penicillin-streptomycin
(Invitrogen) and 10% fetal bovine serum (Hyclone, UT,
USA). At confluence, the cells were subpassaged and
cultured as above. Confluent third passage cultures were
used for the experiments described below. In order to
ensure that these cells retained osteoblastic responses to
1a,25(OH)2D3 at this passage, we examined the dose-
dependent effects of the seco-steroid on cell number,
alkaline phosphatase specific activity and osteocalcin
production. Confluent cultures were treated with 10
-9M
or 10
-8M1 a,25(OH)2D3 for 24 hours.
Validated rat osteoblasts were plated at 20,000 cells/
cm
2 on TCPS, PT and SLA substrates. Media were
exchanged at 24 hours and then every 48 hours until
cells reached confluence on TCPS. At confluence, media
were replaced with experimental media containing vehi-
cle or 1a,25(OH)2D3 (10
-9 and 10
-8M) (Biomol Research
Laboratories, PA, USA) or 10
-9M1 7 b-oestradiol (E2)o r
E2 conjugated to bovine serum albumin (E2-BSA,
Sigma-Aldrich Co, MO, USA), which prevents diffusion
of E2 across the plasma membrane, thereby activating
membrane-mediated E2-signalling [41].
Biochemical analysis
When the osteoblast cultures achieved confluence on
TCPS, all the cultures were treated for 24 hours with
media containing either vehicle or the appropriate hor-
mone concentration. The cell number was determined
at harvest for all the cultures. Cells were released by two
sequential 10 minute incubations in 0.25% trypsin at 37°
C in order to ensure that all cells were removed from
rough Ti surfaces and counted (Z1 cell and particle
counter, Beckman Coulter, CA, USA). In order to mea-
sure the cellular alkaline phosphatase specific activity
[orthophosphoric monoester phosphohydrolase, alkaline;
E.C. 3.1.3.1], cells were lysed by freeze-thawing in Tri-
ton-X100. Enzyme activity in the lysates was assayed by
measuring the release of p-nitrophenol from p-nitrophe-
nylphosphate at pH 10.2 and results were normalized to
the protein content of the cell lysates. Osteocalcin in the
conditioned media was measured using a commercially
available radioimmunoassay kit (Human Osteocalcin
RIA Kit, Biomedical Technologies, MA, USA) and nor-
malized by cell number. The conditioned media were
also assayed for growth factors and cytokines. The pros-
taglandin E2 (PGE2) was assessed using a commercially
available competitive binding radioimmunoassay kit
(Prostaglandin E2 RIA kit, Perkin Elmer, MA, USA).
Active transforming growth factor (TGF)-b1w a sm e a -
sured prior to acidification of the conditioned media,
using an enzyme-linked immunoassay (ELISA) kit speci-
fically for human TGF-b1( T G F - b1D u o S e t ,R & DS y s -
tems, MN, USA). The total TGF-b1 was measured after
acidifying the media and the latent TGF-b1 was defined
as total TGF-b1 minus active TGF-b1. The osteoprote-
gerin (OPG) levels were measured using an ELISA kit
(Osteoprotegerin DuoSet, R&D Systems).
Statistical analysis
The experimental design was controlled as far as possi-
ble in order to ensure that any sex differences were not
due to an artifact. Male or female cells were collected
from a minimum of eight rats each for each experiment.
Rats of the same sex were euthanized on the same day
and cells were harvested together. Male and female cells
were collected one week apart. In order to eliminate the
possibility that differences between male and female cell
behaviour were artifacts of different tissue culture condi-
tions, we strictly controlled the culture conditions and
used the same processes to sterilize the Ti surfaces, cell
isolation procedures, cell seeding densities and culture
media. Moreover, the biochemical analyses were per-
formed at the same time.
Each variable was tested in six independent cultures
for each experiment so that we could statistically com-
pare the responses of the male and female cells to each
s u r f a c ea n dt oe a c hh o r m o n et r e a t m e n to nas p e c i f i c
surface in a single experiment. All the experiments were
repeated in order to ensure the validity of the results.
The data presented are from representative experiments.
The data were first analysed by analysis of variance;
when statistical differences were detected, Student’s
t-test for multiple comparisons using Bonferroni’s
method was used. We compared the responses on each
Ti surface to the response on TCPS for each hormone
treatment. In addition, we compared the response to
each dose of hormone to the response to control media
for each of the surfaces.
Results
Phenotype characterization
Cells isolated from the calvaria of male and female rats
exhibited characteristics typical of osteoblasts (Figure 1).
Confluent cultures of third passage cells exhibited
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blast maturation, which reaches a peak just before
matrix mineralization [42]. In addition, these cells pro-
duced osteocalcin, a later marker of osteoblast matura-
tion, which plays and important part in modulating
hydroxyapatite crystal formation [43]. When grown
under control conditions on TCPS, there was no
evidence of sexual dimorphism between female and
male osteoblasts. Moreover, both female and male cells
exhibited dose-dependent responses to 1a,25(OH)2D3
typical of osteoblasts, characterized by decreased cell
number (Figure 1A), increased alkaline phosphatase spe-
cific activity (Figure 1B) and osteocalcin production
(Figure 1C). Although the effect of 1a,25(OH)2D3 on
alkaline phosphatase was similar in the male and female
cells, the effects of 1a,25(OH)2D3 on cell number and
osteocalcin were more robust in the male cells, indicat-
ing the response to hormonal regulation may have a
sex-specific component.
Cell response to Ti substrates
When female and male cells were cultured on Ti sub-
strates under control conditions, there was no evidence
of sexual dimorphism (Figures 2 and 3). In cultures trea-
ted with media containing the vehicle alone, female cell
numbers were comparable on TCPS and PT but lower
on SLA (Figure 2A); male cell numbers were reduced
on PT and SLA in comparison with TCPS (Figure 2B).
Alkaline phosphatase was reduced on PT and further
reduced on SLA in comparison to TCPS, although
osteocalcin levels were increased on SLA in both male
and female cells, indicating a more differentiated pheno-
type [42]. In a second set of control cultures, alkaline
phosphatase (Figure 3C and 3D) and osteocalcin (Figure
3E and 3F) were increased in male and female cells
grown on SLA, indicating that the cells were harvested
at an early state of differentiation due to small differ-
ences in confluence.
Control cultures of both female and male osteoblasts
exhibited substrate-dependent increases in the produc-
tion of local factors. Female cells exhibited higher levels
of PGE2, a cytokine that regulates osteoblast differentia-
tion [44], in their conditioned media on both Ti sub-
strates compared to TCPS (SLA > PT) whereas male
osteoblasts only had increased PGE2 levels on SLA
(Figure 4A and 4B). Females had higher levels of OPG,
the RANK ligand decoy receptor important in decreas-
ing osteoclastic activity, in their conditioned media than
male cells, regardless of the surface, and exhibited a
greater increase when grown on SLA in comparison to
PT or TCPS (Figure 5A and 5B). Female and male cells
exhibited comparable responses to surface microstruc-
ture with respect to the levels of latent TGF-b1 (Figures
4 Ca n d4 Da n d5 Ca n d5 D )a n da c t i v eT G F - b1( d a t a
not shown; SLA > TCPS), a growth factor that enhances
extracellular matrix production.
Osteoblast response to 17b-oestradiol
Sexual dimorphism was evident in the response of cells
to oestrogen, with responses to the hormone being evi-
dent only in the cells from female rats (Figures 2 and 4).
Figure 1 Osteoblasts from female and male rats exhibit
differential responses to 1a,25(OH)2D3 when cultured on tissue
culture polystyrene. Osteoblasts isolated from the calvaria of
female and male rats were treated for 24 hours with increasing
concentrations of the vitamin D metabolite 1a,25(OH)2D3 at
confluence. Cell number (A), alkaline phosphatase specific activity in
cell lysates (B) and osteocalcin in the conditioned media (C) were
measured after 24 hours of treatment with either vehicle, 10
-9M
1a,25(OH)2D3 or 10
-8M1 a,25(OH)2D3.* P<0.05, 1a,25(OH)2D3
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from male and female rats were plated on Ti surfaces and treated with either E2 or E2 conjugated to bovine serum albumin (BSA; E2-BSA) at
confluence. Cell number (A, B), alkaline phosphatase specific activity in cell lysates (C, D) and osteocalcin in the conditioned media (E, F) were
measured after 24 hours. *P<0.05, Ti surfaces versus tissue culture polystyrene; #P<0.05, oestradiol versus control.
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Page 5 of 11Figure 3 Male osteoblasts respond more robustly to 1a,25(OH)2D3 than females, an effect enhanced on microstructured titanium (Ti).
Confluent cultures of rat calvarial osteoblasts were plated on Ti surfaces and treated with 1a,25(OH)2D3. Cell number (A, B), alkaline phosphatase
specific activity in cell lysates (C, D) and osteocalcin in the conditioned media (E, F) were measured after 24 hour treatment with either vehicle,
10
-9M1 a,25(OH)2D3 or 10
-8M1 a,25(OH)2D3.* P<0.05, Ti surfaces versus tissue culture polystyrene at each concentration; #P<0.05, 1a,25(OH)2D3
versus control; black circle, P<0.05, 10
-9M1 a,25(OH)2D3 versus 10
-8M.
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dependent. E2 caused a decrease in the number of cells
in females on TCPS and PT but had no effect on cell
numbers on the rough SLA surface (Figure 2A). In con-
trast, E2 had no effect on male osteoblast numbers on
any substrate (Figure 2B). E2-BSA did not regulate cell
numbers in either female or male cultures. Both forms
of the hormone stimulated alkaline phosphatase in
female osteoblasts but only in cultures grown on SLA
(Figure 2C). Neither form of oestrogen affected the
enzyme activity in male cells (Figure 2D). Female cells
responded to E2 and E2-BSA with an increase in osteo-
calcin on all surfaces but the percent increase was great-
est in cells grown on SLA (Figure 2E). Neither E2 nor
E2-BSA affected osteocalcin in the male cultures (Figure
2F). E2 and E2-BSA increased PGE2 (Figure 4A) and
latent TGF-b1 (Figure 4C) in the media of female cells
grown on all substrates. Both forms of oestrogen
increased the levels of active TGF-b1 (data not shown).
Neither E2 nor E2-BSA affected the levels of PGE2
(Figure 4B) or of latent (Figure 4D) or active (data not
shown) TGF-b1 in the media of male cells.
Osteoblast response to 1a,25(OH)2D3
As noted above, both male and female cells grown on Ti
responded to 1a,25(OH)2D3 but responses were more
robust in the male cells, particularly on the microstruc-
tured SLA substrates (Figures 3 and 5). 1a,25(OH)2D3
Figure 4 Only female osteoblasts increase production of prostaglandin (PGE2) and transforming growth factor (TGF-b1) after
oestrogen treatment when grown on titanium (Ti) surfaces. Osteoblasts isolated from calvaria of male and female rats were plated on Ti
surfaces. At confluence, cells were treated with E2 or E2-BSA for 24 hours. Levels of PGE2 (A, B) and latent TGF-b1(C, D) were measured in the
conditioned media. *P<0.05, Ti surfaces versus tissue culture polystyrene; #P<0.05, oestradiol versus control.
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c u l t u r e sg r o w no na n yo ft h et e s ts u r f a c e s( F i g u r e3 A
and 3B). Alkaline phosphatase in female cells was
increased by 10
-8M1 a,25(OH)2D3 on all substrates
(Figure 3C). Male cells were more sensitive to 1a,25
(OH)2D3, showing increases at 10
-9M (Figure 3D). 1a,25
(OH)2D3 also affected osteocalcin production in both
the male and female cells on all substrates. However,
female cells exhibited increases only at the higher dose
(Figure 3E). Moreover, male cells exhibited a synergistic
stimulation in osteocalcin production when grown on
SLA and treated with 10
-8M1 a,25(OH)2D3 (Figure 3F).
Female and male osteoblasts responded to 10
-8M1 a,25
(OH)2D3 with an increase in OPG but the effect was
more pronounced in male cells grown on SLA and was
synergistic with surface microstructure (Figure 5A and
5B). 1a,25(OH)2D3 also caused an increase in latent
TGF-b1 levels on all surfaces, with the greatest stimula-
tory effect seen in male cells cultured on SLA and trea-
ted with 10
-8 M1 a,25(OH)2D3.C o m p a r i s o no ft h e
mean percent change in response to 1a,25(OH)2D3 for
female and male cells on each of the test substrates
showed that, overall, male osteoblasts responded more
robustly to the vitamin D metabolite (Table 1).
Figure 5 Male osteoblasts respond more robustly to 1a,25(OH)2D3 than females, an effect enhanced on microstructured titanium (Ti).
Osteoblasts isolated from calvaria of male and female rats were plated on Ti surfaces. At confluence, cells were treated with 1a,25(OH)2D3 for
24 hours. Levels of osteoprotegerin (A, B) and latent tissue culture polystyrene (TCPS)-b1 (C, D) were measured in the conditioned media.
*P<0.05, Ti surfaces versus TCPS; #P<0.05, 1a,25(OH)2D3 versus control; ·P<0.05, 10
-9M1 a,25(OH)2D3 versus 10
-8M.
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Despite the large amount of literature on osteoblasts,
there has been little assessment of whether these bone
forming cells exhibit specific differences related to the
sex of the animals from which they were derived. This
study examined whether osteoblasts isolated from male
and female rats exhibit sexual dimorphism when grown
under standard cell culture conditions, as well as when
grown on substrates used as implants in clinical practice.
In addition, the study addressed the question of whether
or not osteoblasts are sensitive to modifications in sub-
strate microarchitecture and if they respond to osteotro-
pic hormones in a sex-specific manner. This study shows
that, under control conditions whether on TCPS or
smooth or microstructured Ti, there are no apparent dif-
ferences between cells taken from male or female donors.
However, osteoblasts exhibit differences in their
responses to oestrogen and in the robustness of their
responses to 1a,25(OH)2D3 that are sex-dependent.
The present study is limited because it was conducted
in vitro and used rat cells. Thus, the data cannot be cor-
related directly to human cells or to in vivo responses in
humans. Here, all of the rats were of the same strain
while, in contrast, the human population is outbred and,
therefore, inter-human variability may be greater than
the differences between the sexes. The goal of this study
was to compare the response of male and female osteo-
blasts grown on implant surfaces. In our population, we
have a mixture of osteoprogenitor cells and immature
osteoblasts cultured from explants of frontal and parietal
bones. Cells with a similar phenotype will migrate to the
implant surface in vivo, allowing us to mimic the condi-
tions crucial to osseointegration. In order to further this
system, we cultured cells only in DMEM and serum and
did not include any other factors traditionally used -
such as dexamethasone, b-glycerophosphate or ascorbic
acid. In order to minimize the potential differences due
to cell numbers from individual bone samples, cells
were isolated from bones in the same location of the
skull, grown in the same media, seeded at the same den-
sity and treated at confluence. Thus, in this study the
baseline differences between males and females are
underscored. We used sexually mature rats for these
experiments, so differences in exposure to sex steroids
in vivo may have affected the subpopulations of osteo-
blasts isolated from the donor bone.
Even with these limitations, however, the results indi-
cate that there are physiological differences in male and
female osteoblasts and sexual dimorphism in the
response to bone regulating hormones. This difference
is more pronounced when cells are cultured on sub-
strates other than tissue culture polystyrene. Currently,
most preclinical studies of therapeutic interventions are
p e r f o r m e di no n l ym a l eo ro n l yf e m a l ea n i m a lm o d e l s .
Further investigations on sex specific differences should
be performed in order to improve our understanding of
cellular responses to biomaterials.
Both female and male cells exhibited a more mature
phenotype when grown on SLA than when grown on
TCPS or PT. This was indicated by the higher levels of
osteocalcin and OPG in their conditioned media.
Although we had previously shown that male cells and
female cells would exhibit a more differentiated pheno-
type when grown on SLA in comparison to PT [9], we
had not directly compared cells from the same species
cultured under near identical conditions. The present
results remove this ambiguity.
In contrast, the responses of cells cultured on the
microstructured surfaces to 1a,25(OH)2D3 and E2 were
sex-specific. Male cells were more sensitive to 1a,25
(OH)2D3 than female cells, responding at lower concen-
trations. Moreover, the response of the male cells to the
higher concentration of 1a,25(OH)2D3 was more robust.
In addition, only the female osteoblasts exhibited
responses to E2 or E2- B S A .T h i sc o n f i r m so u rp r e v i o u s
results, which showed that osteoblasts from human
females exhibit surface-dependent responses to 17b-
oestradiol [19], but we had not determined if male
osteoblasts would also exhibit a response to E2 or E2-
BSA. Our studies assessing the effects of E2 and E2-
BSA on human articular chondrocytes and rat growth
plate chondrocytes demonstrated that male cells lacked
Table 1 Percent increase in response over control in male and female osteoblasts treated with 10
-8M1 a,25(OH)2D3
% Increase treatment versus control
Sex Surface Cell No. Alkaline Phosphatase Osteocalcin Osteoprotegerin Active TGF-b1 Latent TGF-b1
Male TCPS -4.6 92.5 41.5 185.9 111.8 154.8
PT -11.3 94.7 37.0 219.9 256.4 162.8
SLA -13.6 85.0 71.0 224.2 257.8 236.2
Female TCPS 0.3 45.7 17.3 172.1 81.8 60.7
PT 0.2 43.9 20.5 184.8 77.6 98.8
SLA -3.1 39.4 21.2 141.5 123.3 115.5
TCPS, tissue culture polystyrene; PT, pretreated; SLA, grit-blasted/acid etched.
Olivares-Navarrete et al. Biology of Sex Differences 2010, 1:4
http://www.bsd-journal.com/content/1/1/4
Page 9 of 11ar e s p o n s et o1 7 b-oestradiol and exhibited more robust
responses to 1a,25(OH)2D3 than female chondrocytes
[45], suggesting that these are reflective of general
properties of cartilage and bone cells. Another possibi-
lity is that the male and female rat osteoblasts were at
different states of maturation, since response to these
systemic regulators varies with the state of the cell
within the osteoblast lineage [38].
The mechanisms that mediate these differences are
not clear. One possibility is that there are differences in
vitamin D receptor (VDR) and oestrogen receptor (ER)
expression in female and male cells [30]. Alternatively,
components of the signalling pathways involved may
play a role. Both 1a,25(OH)2D3 and 17b-oestradiol act
via classical steroid hormone receptors and via mem-
brane-dependent signalling pathways. We did not speci-
fically assess whether there were differences in the
membrane signalling by 1a,25(OH)2D3,b u to u rf i n d i n g
that E2-BSA, which cannot enter the cell due to its size
[41], had no effect on male osteoblasts indicates that
this mechanism of oestrogen action is not operative in
cells from male donors. Moreover, E2 acted only on
female osteoblasts in order to reduce cell number, sug-
gesting that even the traditional ER response was not
operational in the male cells. Male rat osteoblasts pos-
sess traditional ERs [46], further supporting the hypoth-
esis that the sex-specific effects noted in the present
study were mediated by signalling pathways not func-
tional in male cells.
The results suggest that the level of osteotropic hor-
mones such as 1a,25(OH)2D3 and 17b-oestradiol is
important to the regulation of osteoblasts during
implant osseointegration. In cases where the hormone
level is reduced, such as in postmenopausal females and
in vitamin D deficiency [24], the success of the implant
may be reduced. In the last decade, an oestrogen effect
on the male skeleton was established, although not as
extensively as in females. During ageing female bone
loss is due to an increased rate of bone resorption,
whereas male bone loss is the result of less bone forma-
tion [47], indicating that different mechanisms are
involved. There is also a sex-related difference in osteo-
cyte lacunar density in human vertebral cancellous bone
[48]. Sexual dimorphism may be attributed to differ-
ences in ER isoform expression [49] or in the number of
receptors [46]. Males with deficiency of ERs or aroma-
tase had defects in skeletal phenotypes [50], indicating
that oestrogen is an important regulator for male cells.
Alternatively, the higher aromatase activity present in
male cells [51] may convert oestrogen to testosterone,
thereby reducing the effective concentration of the hor-
mone in the male cells. Whether these mechanisms
accounted for the lack of a response to oestrogen noted
in the present study is not known.
Conclusions
The results of this study revealed the physiological dif-
ference in male and female osteoblasts and sexual
dimorphism in the response to bone regulating hor-
mones, a difference that is more pronounced when cells
are cultured on substrates other than tissue culture
polystyrene. Currently, most preclinical studies of thera-
peutic interventions are performed in only male or only
female animal models. Further investigations on sex-spe-
cific differences should be performed in order to
improve our understanding of cellular responses to
biomaterials.
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